GlobalData’s director of therapy research & analysis in medical devices says the new entity could make an attractive ...

WALTHAM, Mass. & SAN DIEGO, January 13, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for ...

While much of the focus around in vitro diagnostics has lately been around their utility in the fight against the COVID-19 global pandemic, there is much more going on with IVDs in multiple disease ...

Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...

Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...